Antimicrobial Stewardship and Pandemic Preparedness: Harnessing Lessons Learned to Advance Our Mission

被引:0
作者
Mcsweeney, Terrence [1 ,6 ]
Chang, Mei H. [1 ,5 ]
Patel, Payal [2 ,3 ,4 ]
Nori, Priya
机构
[1] Montefiore Hlth Syst, Dept Pharm, Bronx, NY USA
[2] Intermt Healthcare, Div Infect Dis & Clin Epidemiol, Murray, UT USA
[3] Intermt Med Ctr, Infect Dis Clin, 5171 Cottonwood St,Suite 350, Murray, UT 84107 USA
[4] Albert Einstein Coll Med, Montefiore Hlth Syst, Dept Med, Div Infect Dis, 3411 Wayne Ave 4H, Bronx, NY 10467 USA
[5] 1825 Eastchester Rd, Bronx, NY 10461 USA
[6] 3411 Wayne Ave 4H, Bronx, NY 10467 USA
关键词
Antimicrobial stewardship; Pandemic stewardship; Antimicrobial resistance; INFECTIOUS-DISEASES SOCIETY; HEALTH-CARE EPIDEMIOLOGY; AMERICA; GUIDELINES; RESISTANCE; HOSPITALS; PROGRAMS;
D O I
10.1016/j.idc.2023.07.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
center dot Public health policy addressing the threat of antimicrobial resistance (AMR) has greatly increased momentum for antimicrobial stewardship programs (ASPs) worldwide.center dot ASPs reoriented traditional responsibilities to better serve the COVID-19 pandemic response. Such "pandemic stewardship" functions can be escalated and de-escalated as needed to serve emerging public health emergencies.center dot Although ASPs were assuming functions outside their traditional roles, they were unable to monitor antibiotic use or provide audit and feedback to the usual extent. Increased anti-biotic use, hospital-acquired infections, and AMR were observed during the height of COVID-19. In the event of future pandemics, increased resources for stewardship pro-grams will be required to meet the needs of health systems.center dot ASPs have evolved to offer more robust services within the health care system; as such, current metrics used to measure impact and staffing ratios should be reevaluated.center dot The future of ASP is likely to involve health system expansion, expansion into outpatient and post-acute care settings, and stewarding of immune-based and microbiome therapeutics.
引用
收藏
页码:669 / 681
页数:13
相关论文
共 62 条
[1]  
Ahmad H., 2012, HOSP PHARM, V47, P532, DOI [DOI 10.1310/hpj4707-532, 10.1310/hpj4707-532]
[2]  
[Anonymous], 2022, COVID-19: U.S. Impact on Antimicrobial Resistance, DOI 10.15620/cdc:117915
[3]  
[Anonymous], 2022, 2021 ANTIBACTERIAL A
[4]  
[Anonymous], 2023, VOWST (fecal microbiota spores live-brpk) package insert
[5]  
[Anonymous], 2022, REBYOTA (fecal microbiota live-jslm) package insert
[6]  
[Anonymous], Library of AMR national action plans
[7]   Global collaborations in antimicrobial stewardship: All hands on deck [J].
Ashiru-Oredope, Diane ;
Langford, Bradley J. ;
Bonaconsa, Candice ;
Nampoothiri, Vrinda ;
Charani, Esmita ;
Goff, Debra A. .
ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2023, 3 (01)
[8]   Expanding the scope and visibility of ambulatory stewardship programs with novel coronavirus disease 2019 (COVID-19) therapeutics [J].
Bao, Hongkai ;
Guo, Yi ;
Chang, Mei H. ;
McSweeney, Terrence ;
Golia, Austin M. ;
Cowman, Kelsie ;
Bartash, Rachel ;
Anosike, Brenda I. ;
Nori, Priya .
ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2022, 2 (01)
[9]   Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic [J].
Bariola, J. Ryan ;
McCreary, Erin K. ;
Khadem, Tina ;
Snyder, Graham M. ;
Wadas, Richard J. ;
Nace, David A. ;
White, Douglas B. ;
Yealy, Donald M. ;
Schmidhofer, Mark .
OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (07)
[10]  
Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118